Izifundo ezithathu ezitsha ezenziwa yi-US Amaziko oLawulo lweSifo kunye noThintelo (CDC) tyhila ukuba iPfizer-BioNTech kunye neModerna booster shots bezisebenza ngama-90% ekukhupheni abantu esibhedlele emva kokuba bosulelwe yi-Omicron eyahlukileyo yentsholongwane ye-COVID-19.
Iidosi ze-booster zibonakalise ukuba zisebenza kakhulu ekuthinteleni Micron-esibhedlele ezinxulumene, ngokutsho CDC.
I-Booster jabs nayo i-82% esebenzayo ekuthinteleni isebe eliphuthumayo kunye nokutyelelwa ngononophelo oluphuthumayo, idatha yophando ibonisiwe.
Uphando luquka izifundo zokuqala ezinkulu zase-US ukujonga ukhuseleko lwesitofu ngokuchasene Micron, amagosa ezempilo athi.
"Abantu baseMelika kufuneka bafumane ii-boosters ukuba ubuncinci iinyanga ezintlanu begqibile uthotho lwabo lwePfizer okanye iModerna, kodwa izigidi ezifanelekileyo azikazifumana," CDC's Emma Accorsi, omnye wababhali isifundo wathi.
Amaphepha athetha ngophando lwangaphambili-kubandakanya izifundo eJamani, eMzantsi Afrika nase-United Kingdom- ebonisa ukuba izitofu zokugonya ezikhoyo azisebenzi kangako kwi-Omicron kuneenguqulelo zangaphambili zekoronavirus, kodwa kwakhona ukuba idosi ebooster ivuselela izilwa-ntsholongwane ezilwa nentsholongwane ukonyusa ithuba lokuphepha. usulelo oluneempawu.
INTO ONOKUYITHATHA KWELI NQAKU:
- Amaphepha athetha ngophando lwangaphambili-kubandakanya izifundo eJamani, eMzantsi Afrika nase-United Kingdom- ebonisa ukuba izitofu zokugonya ezikhoyo azisebenzi kangako kwi-Omicron kuneenguqulelo zangaphambili zekoronavirus, kodwa kwakhona ukuba idosi ebooster ivuselela izilwa-ntsholongwane ezilwa nentsholongwane ukonyusa ithuba lokuphepha. usulelo oluneempawu.
- Three new studies by the US Centers for Disease Control and Prevention (CDC) reveal that Pfizer-BioNTech and Moderna booster shots were 90% effective at keeping people out of hospital after they had contracted the Omicron variant of the COVID-19 virus.
- “Americans should get boosters if at least five months have passed since they completed their Pfizer or Moderna series, but millions who are eligible have not gotten them,” the CDC's Emma Accorsi, one of the study's authors said.
